ARTICLES

Filter  
Active filters 0
Remove
  

Refine your searches by:

Collections
Medicine / Pharmacology
Medicine / Sub specialtie
Public health
Medicine / Gynecology
Pure sciences
Research
Biology
Veterinary
Medicine / Nursing
Architecture and Urbanism
all records (13)

Languages
English
Spanish
Portuguese

Countries
Indonesia
USA
Italy
Macedonia
Brazil
Spain
Pakistan
Bangladesh
Cuba
Bosnia Herzegovina
all records (18)

Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
all records (16)

Filter  
 
62  Articles
1 of 7 pages  |  10  records  |  more records»
 C-peptide is part of the, which its amounts were equal to endogenous insulin secreted by pancreatic ß cells. Carboplatin is one of the chemotherapy regimens that are widely used to treat gynecological malignancies. Carboplatin may cause the damage o... see more

Los compuestos de platino son ampliamente utilizados en diferentes tumores, siendo carboplatino el indicado en carcinoma de ovario. La principal toxicidad limitante de dosis de carboplatino es la trombopenia, sin embargo, en ocasiones presenciamos reaccio... see more

Los compuestos de platino son ampliamente utilizados en diferentes tumores, siendo carboplatino el indicado en carcinoma de ovario. La principal toxicidad limitante de dosis de carboplatino es la trombopenia, sin embargo, en ocasiones presenciamos reaccio... see more

This study is aimed to compare the difference of neutropenia with peripheral neuropathy condition, after administration of 3 hours and 24 hours Paclitaxel infusion in adjuvant therapy with Paclitaxel­Carboplatin toward patient with ovarian carcinoma. The ... see more

Introduction:The incidence of hearing loss after treatment with carboplatin-based chemotherapy in nasopharyngeal carcinoma (NPC) patients were evaluated, and relationships of loss with host factors, treatment-related factors were investigated.Objective:To... see more

We investigated dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment on stage II-IV ovarian cancer patients. Between July, 2011, and October, 2014, a total of 221 patients was randomly assigned to re... see more

BackgroundEpithelial ovarian cancer (EOC) is one of the most common cancers diagnosed in Indonesian women. A combination of paclitaxel and carboplatin is used to treat EOC as standard chemotherapy which is known to have hematologic toxicities. This study ... see more

Tujuan: Mengetahui perbandingan respon terapi dan toksisitas regimen kemoterapi kombinasi Paclitaxel Carboplatin Ifosfamide dengan Paclitaxel Carboplatin pada kanker serviks stadium IIB.Metode: Sebanyak 30 pasien yang baru terdiagnosis kanker serviks stad... see more

Objective: To analyze the effects of carboplatin combined with paclitaxel-based intraperitoneal hyperthermic perfusion chemotherapy (IPCH) on serum levels of human epididymis protein 4 (HE4) and mitogen-dependent oncogene-1 (DJ-1) in patients with advance... see more

1 of 7 pages  |  10  records  |  more records»